By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Acetylon Pharmaceuticals 



Boston  Massachusetts    U.S.A.
Phone: 617-435-2664 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Acetylon Pharmaceuticals Presents Positive Preclinical Data On Selective HDAC1/2 Inhibition For The Treatment Of Sickle Cell Disease/?-Thalassemia 12/9/2014 1:48:47 PM
Acetylon Pharmaceuticals Announces Ricolinostat Continues To Demonstrate Clinically Meaningful And Durable Disease Response Rates In Phase 1b Combination Studies In Multiple Myeloma 12/9/2014 11:12:07 AM
Acetylon Pharmaceuticals Initiates Phase 2 Study Of Ricolinostat (ACY-1215) In Combination With Pomalyst® 12/4/2014 9:34:25 AM
Acetylon Pharmaceuticals’s Selective HDAC Inhibitors To Be Featured In Multiple Presentations Of Positive Clinical And Preclinical Data At The 56th American Society of Hematology Annual Meeting And Exposition 12/1/2014 2:45:37 PM
Acetylon Pharmaceuticals Reports Ricolinostat (ACY-1215) Is Active And Well-Tolerated In Ongoing Phase 1b Studies In Patients With Refractory Multiple Myeloma At The 19th Congress Of The European Hematology Association 6/13/2014 12:02:38 PM
Acetylon Pharmaceuticals Celebrates Headquarters Expansion In Boston’s Innovation District 3/20/2014 10:09:04 AM
Acetylon Pharmaceuticals Presents Data On The Potent Activity Of Ricolinostat (ACY-1215) In Preclinical Models Of Lymphoma At The American Society of Hematology Annual Meeting 12/10/2013 12:04:01 PM
Acetylon Pharmaceuticals Highlights Positive Interim Phase 1b Clinical Data Of Ricolinostat (ACY-1215) In Multiple Myeloma At American Society of Hematology Annual Meeting 12/10/2013 10:18:15 AM
Acetylon Pharmaceuticals Presents Preclinical Data for Selective HDAC1/2 Inhibitors For The Treatment Of Sickle Cell Disease And ß-Thalassemia At The American Society of Hematology Annual Meeting 12/10/2013 6:51:51 AM
Acetylon Pharmaceuticals’ Selective Hdac Inhibitors In Multiple Myeloma, Lymphoma And Sickle Cell Disease And ?-Thalassemia To Be Featured In 11 Presentations At American Society of Hematology Annual Meeting 11/25/2013 8:51:15 AM
1234
//-->